Peloton Wealth Strategists’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.64M Buy
184,250
+50,750
+38% +$1.28M 1.72% 19
2026
Q1
$3.37M Buy
133,500
+39,000
+41% +$995K 1.36% 27
2025
Q4
$2.41M Buy
94,500
+38,500
+69% +$985K 0.94% 38
2025
Q3
$1.44M Buy
56,000
+3,500
+7% +$88.8K 0.56% 60
2025
Q2
$1.33M Hold
52,500
0.53% 61
2025
Q1
$1.31M Buy
52,500
+7,500
+17% +$186K 0.55% 58
2024
Q4
$1.11M Buy
45,000
+4,000
+10% +$100K 0.45% 64
2024
Q3
$1.05M Buy
41,000
+3,000
+8% +$75.8K 0.42% 65
2024
Q2
$933K Buy
38,000
+9,000
+31% +$220K 0.38% 65
2024
Q1
$719K Hold
29,000
0.29% 71
2023
Q4
$732K Buy
+29,000
New +$692K 0.32% 68

Other funds holding IBDX

Peloton Wealth Strategists's IBDX Position: Q2 2026 in Review

Peloton Wealth Strategists increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 38% in Q2 2026, buying an estimated $1.28M and bringing the position to 184,250 shares worth $4.64M. The position accounts for 1.72% of the portfolio, ranked #19.

Peloton Wealth Strategists first reported a position in IBDX in Q4 2023 and has held it in 11 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Peloton Wealth Strategists held 184,250 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $4.64M as of Q2 2026.
  • Peloton Wealth Strategists bought 50,750 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $1.28M.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.72% of Peloton Wealth Strategists's portfolio in Q2 2026, its #19 holding.
  • Peloton Wealth Strategists first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Peloton Wealth Strategists's 13F filing for Q2 2026, filed 10 Aug 2026.